Off-Topic — Like This — Not Much of What Came Much Later. . . .
June 25, 2009 · Leave a Comment
Categories: Uncategorized
Tagged: RIP MJ Namaste 2009
Main Site [For which this Serves a Mere Back-Up!]
By Date
Monthlies
By categories. . .
-
What’s poppin’
- condor on New Boxed Warnings From FDA: On Remicade®, and Simponi®
- Cure For Psoriasis on New Boxed Warnings From FDA: On Remicade®, and Simponi®
- ahrcanum on A Renewed Ray of Hope — For An HIV Vaccine — “Some Day”
- Options Training on Post-Retirement Pay Rising For Many CEOs — Hassan, Especially: $175 Million Worth
- Coder67 on Why Is Schering-Plough’s “Investor FAQ” Archive Page No Longer Indexed on Its Site?
Tags — we’ve also got tags!
2009 Abbott Miles White WSJ DoJ HSR Merial Intervet Pfizer Wyeth Animal Health FTC Hart Scott Divestitures Overlap Sanofi ECC Antitrust Reverse Merger October 23 2009 Additional Salmon's Asenapine Chronicles Erstwhile Salmon FDA PDAC July 30 2009 Meeting July 28 2009 Additional Salmon's Asenapine Chronicles Erstwhile Salmon FDA PDAC Phen-Fen Repeat July 31 2009 Air Hassan Carrie Cox American Air Parody Image Pharmacia Merck Payouts Manson 08-397 May 17 2009 Bad for Schering Boceprivir Good for Vertex Telaprevir Bad for Schering Boceprivir Good for Vertex Telaprevir UBS Conference Hep C candidate Phase 2 Phase 3 FDA chemistry Hep C EFFICACY November 2 2009 Bayer Behringer Merial Intervet Pfizer Wyeth Animal Health FTC Hart Scott Divestitures Overlap Sanofi ECC Antitrust Reverse Merger August 18 2009 Boceprevir Schering Plough Hep C Phase II Teleprevir Ph Cain v. Hassan Becherer ENHANCE stock options 2008 gran Celgene Carrie Smith Cox Pharmacia Upjohn Pfizer Largest Federal Criminal Fine Ever Searle Bextra Celebrex December 17 2009 CEO vote Becherer vote on retention by shareholders at the Annual Meeting of Shareholders in Chicago May 18 2009 Constitutional law first amendment video House Rule XI Cylatron EMEA Peginterferon Alpha-2b Fail Pegintron August 24 2009 DoJ HSR Comments Second Request Bayer Behringer Merial Intervet Pfizer Wyeth Animal Health FTC Hart Scott Divestitures Overlap Sanofi ECC Antitrust Reverse Merger August 20 2009 DoJ HSR Comments Second Request Bayer Behringer Merial Intervet Pfizer Wyeth Animal Health FTC Hart Scott Divestitures Overlap Sanofi ECC Antitrust Reverse Merger August 21 2009 ESC FDA SEAS Munich Germany Tuseday Dear Doctor letter FDA ODAC Pegintron October 1 2009 Foradil Asthma LABA Motley Fool risk of death WSJ FDA r FTC Second Request SGP Merck Merial Intervet Animal Health Businesses HSR Required Divestitures June 22 2009 Golden Gate Pharmacy v. Pfizer Wyeth 09-3854 Merck Schering Bust Up EBITDA v. Sales Analysis August 23 2009 Hassan/Clark Schering/Merck JNJ arbitration clause Weldon bust-up JNJ Q1 2009 Call change of control Remicade Simponi August 5 2009 Health Care Reform Hearings Remarks Senate Finance Comm Herper Forbes Stein Taylor PM Gooznews SEAS Cancer Krum Ice Cream Wars at Trade Shows Trivia Hassan WhiteCoat Blog October 20 2009 In Re Vytorin/Zetia Marketing Krumholz Harlan Yale JAMA VIOXX Heart Attack Data Known or Knowable in 2001 through 2004 November 23 2009 Low Quality in Health Care The Necessity for Reform Sen Manson v. Schering-Plough Corporation Securities Fraud Merck Fosamax Bone Density Osteonecrosis Claims Jaw Jury Trial Deliberations Underway Intimidation US Dist Ct NY September 11 2009 Merck Fosamax Bone Density Osteonecrosis Claims Jaw US Dist Ct NY August 11 2009 Merck Merial Intervet Option to Sell Sanofi Aventis Animal Health FTC Hart Scott Divestitures Overlap Antitrust Reverse Merger July 31 2009 Merck Schering Plough COnfidential Treatment Joint Vent Merck VIOXX 2004 DoJ Criminal Grand Jury Target Letter Wells Notice March 23 2009 Olympics Opening Ceremonies 2008 Beijing London 2012 08 Products Liability Litigation MDL No. 1938 July 17 2008 Salmon July 30 2009 FDA Advisory Committee Meeting FAQs Saphris Asenapine Delay TRA delay June 10 2009 SEAS IMPROVE-IT Dr. Allen Taylor NEJM Heart.org FierceBiotech SEAS cancer signal letter Peto Califf Questions Schering August 17 2009 Singulair Teva Merck Insurers Wholesalers Antitrust Patent Invalidity Obviousness August 17 2009 sugammadex UnitedHealth Insurer sponsored studies Vytorin No Benefit AHA Orlando Novmeber 18 2009 Vioxx securities claims reinistated implications USSCT SCOTUS Argument November 30 2009 Echo of Vytorin Schering November 30 2009 Vytorin Marketing Sales Products Liability Litigation M William C. Weldon Johnson and Johnson Hassan CEO Scheri WSJ DoJ HSR Merial Intervet Pfizer Wyeth Animal Health FTC Hart Scott Divestitures Overlap Sanofi ECC Antitrust Reverse Merger October 15 2009
Blog at WordPress.com. Theme: Cutline by Chris Pearson.
0 responses so far ↓
There are no comments yet...Kick things off by filling out the form below.